Helicobacter pylori (HP) type and drug-resistant mutation gene detection kit
A technology for Helicobacter pylori and drug-resistant mutations, applied in the direction of microorganism-based methods, microorganism measurement/testing, microorganisms, etc., can solve the problems of limited mutation types and high cost, and achieve a comprehensive effect of mutation types
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0061] Embodiment 1 The implementation of the concrete technical scheme of the present invention
[0062] 1. Technical basis
[0063] 1.1 Design and implement primers and amplification reaction solution according to the known HP genome sequence.
[0064] The main research content is: according to the sequence characteristics of UreA, CagA, and VacA genes in the HP genome, design PCR primers to amplify the target fragments for typing detection; according to the 23S rRNA, 16S rRNA, rdxA genes, PBP1 Gene and gyrA gene sequence characteristics, design PCR primers to amplify the target fragments for drug resistance detection; in addition, IC internal control is also designed to monitor the entire experimental process.
[0065] The PCR reaction solution is divided into 4 tubes, two tubes of typing reaction solution (the first tube of VacA gene intermediate region primer and signal sequence primer, the second tube of UreA and CagA gene amplification primers), two tubes of drug resis...
Embodiment 2
[0113] Use of Helicobacter pylori typing and drug-resistant mutation gene detection kit of the present invention
[0114] 1. Uses: HP typing and drug-resistant mutation gene detection for patients with gastritis, gastric ulcer, and gastric erosion before initial treatment or retreatment can:
[0115] 1. Distinguish type I and type II, and determine the virulence of Helicobacter pylori;
[0116] 2. Detect 15 mutation types at 9 hotspot mutation sites of 5 HP therapeutic drugs;
[0117] 3. Assist in determining individualized clinical diagnosis and treatment plans, and conduct HP epidemiological research.
[0118] 2. Background of clinical indications:
[0119] Helicobacter Pylori (HP) was first isolated from the gastric mucosa of gastritis patients in 1983 by Barry J. Marshall and J. Robin Warren. Studies have shown that inflammation caused by HP can lead to atrophic gastritis, intestinal metaplasia, dysplasia, and eventually gastric adenocarcinoma.
[0120] HP contains two...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com